Cirencester-based Corin Group celebrated 5,000th operation
PUBLISHED: 10:15 13 September 2017
Surgeons in Australia have performed a landmark medical procedure thanks to groundbreaking technology developed by a Cotswold company
Corin Group makes state-of-the-art hip and knee replacements which it exports to leading orthopaedic specialists in Australia, the US and UK.
Now orthopaedic surgeon Dr Richard Boyle, chair of the Northside Board of Studies at the Australian Orthopaedic Association, has performed the 5,000th total hip replacement using Corin’s patented Optimised Positioning System technology.
Dr Boyle also performed the very first OPS hip replacement and the procedure, at the Royal Prince Alfred Hospital in Sydney, marks a significant milestone in the Corinium Centre’s research and development programme.
The award-winning technology was borne out of years of research showing that because every patient’s pelvis moves differently, the historic one-size-fits-all approach to hip replacements was flawed.
Establishing pre-operatively how each patient’s pelvis rotates when they sit, stand and carry out various activities, showing the relationship between spine, pelvis and femur, is fed into Corin’s specialised engineering software to create a 3D image.
That image is then used to inform the position of laser beams which, while the patient is lying on the operating table, allows the surgeon to accurately position the acetabulum, or cup, in which the femoral head - the hip’s ball joint - sits.
It means surgery is tailored to each patient, reducing historic complications including squeaking, accelerated surface wear and dislocation.
The 5,000th operation was carried out in Sydney, though the procedure is performed all over the world and the company recently presented the technology to surgeons in Bangladesh.
Corin’s new technology - Remote Patient Management (RPM) - is about to be released, which will help surgeons assess which patients are most suited to hip replacements, and allows them to track their progress post-discharge.
Dr Boyle said: “It’s terrific to work so closely with the OPS team to drive personalisation in total hip arthroplasty. Ultimately, we believe this technology will deliver improved results over the longer term.”
A spokesman for Corin said: “Over the past few years we have focused on a more technology-driven strategy including OPS.
“We have continued to develop clinically-proven products as well as embark on a series of acquisitions.
“This combination allows us to compete on the global stage in a competitive, agile fashion.”
Corin employs 300 people across its offices in Cirencester, the US and Europe.